Sort
48,018 grants matching “immunotherapy”
Th9 cells and protective TB immunity
$667,594Daniel F. Hoft · Saint Louis University · R01 · FY2025 · AI
Th9 cells and protective TB immunity
$667,594Daniel F. Hoft · Saint Louis University · R01 · FY2022 · AI
Th9 cells and protective TB immunity
$667,594Daniel F. Hoft · Saint Louis University · R01 · FY2023 · AI
Translating buccal nanocytology for lung cancer screening into clinical practice
$667,591Vadim Backman · Northwestern University · R01 · FY2025 · CA
Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
$667,561Anne Josephine Novak · Mayo Clinic Rochester · R01 · FY2017 · CA
Improving Mucosal Melanoma Therapy by Harnessing the Immunogenicity of r3LCMV
$667,553Seth M Pollack · Northwestern University At Chicago · R01 · FY2025 · CA
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
$667,493Lawrence Corey · Fred Hutchinson Cancer Center · R01 · FY2022 · AI
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
$667,493Lawrence Corey · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI
Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections
$667,493Lawrence Corey · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Tousled like kinase signaling in cancer
$667,363Travis Stracker · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cancer Chemotherapy Training Program
$667,332Sloan-Kettering Institute For Cancer Res · T32 · FY2004 · CA
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$667,257John H Sampson · Duke University · P01 · FY2014 · CA
Selective disruption of histone deacetylase complexes using protein interaction modulators
$667,246Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Costimulation blockade, chimerism and tolerance across varying degrees of MHC dis
$667,222Christian P Larsen · Emory University · U19 · FY2011 · AI
Lymphoma Studies
$667,177Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer
$667,174Amir Horowitz · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Development and validation of an autologous mouse model for the study of immune interactions with glioblastoma
$667,171Zev Ari Binder · University Of Pennsylvania · R37 · FY2025 · CA
Clinical Trials of Patients with AIDS-Related Malignancies
$667,108Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Fruit exosome-like particles for therapeutic delivery of extracellular miRNAs
$667,057Huang-Ge Zhang · University Of Louisville · UH3 · FY2015 · TR
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$666,956Benjamin G. Neel · New York University School Of Medicine · R01 · FY2024 · CA
Mechanistic Virology Core
$666,782Kartik Chandran · Scripps Research Institute, The · U19 · FY2016 · AI
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$666,767Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2022 · CA
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$666,767Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2023 · CA
Targeting head and neck cancer cells and the adverse tumor microenvironment with a novel small-molecule STAT3 inhibitor
$666,718David John Tweardy · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Gamma delta T cell based melanoma therapies
$666,701Xiaowei Xu · University Of Pennsylvania · R01 · FY2022 · CA